DOCU.NASDAQDocusign, INC

Form 4: DocuSign Director Daniel Springer Executes Stock Options and Sells Shares

Sentiment:

SEC Form 4 Filing


Director Daniel Springer exercised stock options and sold DocuSign shares on August 1, 2024, according to a Form 4 filing with the SEC.

Summary

  • On August 1, 2024, Daniel Springer, a director at DocuSign, exercised stock options to acquire 143,054 shares of common stock at a price of $18.02 per share.
  • Following the exercise of options, Springer sold a total of 287,052 shares of DocuSign common stock in multiple transactions.
  • The sales were executed at varying prices, with one batch of 219,933 shares sold at prices ranging from $53.15 to $54.14, another batch of 63,117 shares sold at prices ranging from $54.16 to $55.10, and a smaller batch of 4,002 shares sold at $55.44.
  • After these transactions, Springer directly owns 923,445 shares of DocuSign common stock and indirectly owns 139,825 shares through The Daniel Springer Revocable Trust.
  • Springer also holds options to purchase 989,632 shares of DocuSign common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but the market's interpretation of the transactions could influence the stock price.

Industry Context

This filing reflects insider trading activity, which is a common occurrence for executives and directors of publicly traded companies. These transactions are closely monitored by investors for insights into management's perspective on the company's value and future prospects.

Comparison to Industry Standards

  • It's common for executives at publicly traded companies like Adobe (ADBE) or Salesforce (CRM) to have stock option plans and engage in similar transactions.
  • The scale of these transactions is typical for a director at a company of DocuSign's size, but the specific impact depends on the individual's overall holdings and the market's perception of the sales.
  • Comparing Springer's transactions to those of other DocuSign insiders or executives at peer companies can provide a more comprehensive understanding of the significance of these sales.

Stakeholder Impact

  • Shareholders may react to the news of insider selling, potentially impacting the stock price.
  • The transactions themselves have no direct impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
01/11/2018Initial vesting date for 25% of the shares subject to the option.
01/22/2027Expiration date of the stock options.
08/01/2024Date of the stock option exercise and share sales.
08/02/2024Date of the signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.